Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Joseph L. Reiz"'
Publikováno v:
Journal of attention disorders. 24(3)
Objective: The aim of this study is to assess the onset and duration of efficacy of multilayer-release methylphenidate (PRC-063) over 16 hr compared with placebo in adults with ADHD using the simulated adult workplace environment. Method: After dose-
Autor:
Joseph L. Reiz, Graeme A.E. Donnelly, Zoltan Harsanyi, Jennifer Crosbie, Andrew C. Darke, Russell Schachar, Abel Ickowicz, Paula C. Miceli
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 18:11-24
The aim of this study was to compare the pharmacodynamics of a new multilayer-release (MLR) formulation methylphenidate (MPH; Biphentin) with immediate-release (IR) MPH (Ritalin) in a double-blind, cross-over, placebo-controlled study in patients wit
Publikováno v:
Clinical Therapeutics. 30:59-69
Objective: This study was conducted to compare plasma levels of methylphenidate over time with single doses of a multilayer-release (MLR) bead formulation and an osmotic, controlled-release oral delivery system (OROS) of methylphenidate in young adul
Publikováno v:
The Journal of Clinical Pharmacology. 47:351-357
Oxybutynin is used to treat patients with urinary urgency, frequency, and urge incontinence. In this 2-way, multiple-dose, crossover study, the pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin were compared with immed
Autor:
Joseph L. Reiz, Lily Hechtman, Margaret D. Weiss, Zoltan Harsanyi, Umesh Jain, Graeme A.E. Donnelly, Tahira S. Ahmed, Andrew C. Darke
Publikováno v:
The Journal of Clinical Psychiatry. 68:268-277
Objective To evaluate the efficacy and safety of a new biphasic multilayer-release (MLR) methylphenidate formulation in a double-blind, placebo-controlled crossover study of adults with attention-deficit/hyperactivity disorder (ADHD). Method Adults 1
Autor:
Andrew C. Darke, Jaques Corcos, Joseph L. Reiz, Paula C. Miceli, Allan Patrick, Richard Casey, Cal Andreou, Zoltan Harsanyi
Publikováno v:
BJU International. 97:520-527
OBJECTIVE To assess the efficacy, incidence of dry mouth and overall satisfaction with initial doses of 5, 10 and 15 mg of a new, once-daily, controlled-release (CR) form of oxybutynin for treating urge urinary incontinence (UUI). PATIENTS AND METHOD
Autor:
Andrew C. Darke, Joseph L. Reiz, Zoltan Harsanyi, Sidney B. Radomski, Jacques Corcos, Paula C. Miceli, Marie-Paule Jammal, Jack Barkin
Publikováno v:
Clinical Therapeutics. 26:1026-1036
Objective: The aim of this study was to evaluate the efficacy and safety of a new PO controlled-release (CR) QD oxybutynin tablet relative to PO immediate-release (IR) TID oxybutynin in patients with urge urinary incontinence (UI). Methods: In this m
Autor:
Paula C. Miceli, Zoltan Harsanyi, Lance W. Payne, Frances Chung, Andrew C. Darke, Doris Tong, Joseph L. Reiz
Publikováno v:
Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 51:216-221
Following ambulatory surgery, long-acting analgesics may provide advantages over short-acting analgesics. This study compared controlled-release codeine (CC) and acetaminophen plus codeine (A/C; 300 mg/30 mg) for pain control in the 48-hr period foll
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 55:S219-S220
Autor:
Joseph L. Reiz, Sohail Khattak, Margaret D. Weiss, Graeme A.E. Donnelly, Andrew J. Cutler, Scott H. Kollins
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 55:S217-S218